Boehringer reps win overtime ruling

Boehringer-Ingelheim sales reps may be awarded back pay for all unpaid overtime they've worked, after a legal victory in a Connecticut federal court; the ruling could also affect cases involving reps at Amgen and Serono, BNet Pharma reports. Report

Suggested Articles

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.